UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy

Journal of clinical oncology, 2021-03, Vol.39 (7), p.734-747

2021

Volltextzugriff (PDF)

Using Cost-Effectiveness Analysis to Address Health Equity Concerns

Value in health, 2017-02, Vol.20 (2), p.206-212

2017

Volltextzugriff (PDF)

Cost-effectiveness of gasless laparoscopy as a means to increase provision of minimally invasive surgery for abdominal conditions in rural North-East India

PloS one, 2022-08, Vol.17 (8), p.e0271559-e0271559

2022

Volltextzugriff (PDF)

Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia

Health policy and planning, 2018-04, Vol.33 (3), p.456-463

2018

Volltextzugriff (PDF)

Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results

Blood cancer journal (New York), 2022-04, Vol.12 (4), p.52-52, Article 52

2022

Volltextzugriff (PDF)

Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT

Health technology assessment (Winchester, England), 2018-06, Vol.22 (34), p.1-280

2018

Volltextzugriff (PDF)

What factors affect patients' access to healthcare? Protocol for an overview of systematic reviews

Systematic reviews, 2020-01, Vol.9 (1), p.18-18, Article 18

2020

Volltextzugriff (PDF)

Economic evaluation alongside a randomised controlled trial to assess the effectiveness and cost-effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy

Acupuncture in medicine : journal of the British Medical Acupuncture Society, 2021-02, Vol.39 (1), p.41-52

2021

Volltextzugriff (PDF)

Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

Health technology assessment (Winchester, England), 2019-11, Vol.23 (62), p.1-94

2019

Volltextzugriff (PDF)

The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor

Trials, 2020-10, Vol.21 (1), p.826-826, Article 826

2020

Volltextzugriff (PDF)

An intervention to support stroke survivors and their carers in the longer term: results of a cluster randomised controlled feasibility trial (LoTS2Care)

Pilot and feasibility studies, 2023-03, Vol.9 (1), p.40-40, Article 40

2023

Volltextzugriff (PDF)

What factors affect patients’ ability to access healthcare? An overview of systematic reviews

Tropical medicine & international health, 2021-10, Vol.26 (10), p.1177-1188

2021

Volltextzugriff (PDF)

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

The lancet oncology, 2019-12, Vol.20 (12), p.1760-1772

2019

Volltextzugriff (PDF)

Reply to H. Shojima et al

Journal of clinical oncology, 2021-08, Vol.39 (23), p.JCO2100684-2634

2021

Volltextzugriff (PDF)

Training Program in Gasless Laparoscopy for Rural Surgeons of India: Evaluation and Cost Analysis

Journal of the American College of Surgeons, 2021-11, Vol.233 (5), p.S110

2021

Volltextzugriff (PDF)

An intervention to increase physical activity in care home residents: results of a cluster-randomised, controlled feasibility trial (the REACH trial)

Age and ageing, 2021-11, Vol.50 (6), p.2063-2078

2021

Volltextzugriff (PDF)

Cost‐effectiveness analysis of a multi‐dimensional intervention to reduce inappropriate antibiotic prescribing for children with upper respiratory tract infections in China

Tropical medicine & international health, 2018-10, Vol.23 (10), p.1092-1100

2018

Volltextzugriff (PDF)

Cost-effectiveness of gasless laparoscopy as a means to increase provision of minimally invasive surgery for abdominal conditions in rural North-East India

PloS one, 2022-01, Vol.17 (8)

2022

Volltextzugriff (PDF)

Frailty-Adjusted Therapy in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (FiTNEss): A UK Myeloma Research Alliance Study, Myeloma XIV

Blood, 2019-11, Vol.134 (Supplement_1), p.3153-3153

2019

Volltextzugriff (PDF)

Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa

Value in health regional issues, 2019-09, Vol.19, p.65-74

2019

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy

Using Cost-Effectiveness Analysis to Address Health Equity Concerns

Cost-effectiveness of gasless laparoscopy as a means to increase provision of minimally invasive surgery for abdominal conditions in rural North-East India

Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia

Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results

Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT

What factors affect patients' access to healthcare? Protocol for an overview of systematic reviews

Economic evaluation alongside a randomised controlled trial to assess the effectiveness and cost-effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy

Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial

Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial

Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor

An intervention to support stroke survivors and their carers in the longer term: results of a cluster randomised controlled feasibility trial (LoTS2Care)

What factors affect patients’ ability to access healthcare? An overview of systematic reviews

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

Reply to H. Shojima et al

Training Program in Gasless Laparoscopy for Rural Surgeons of India: Evaluation and Cost Analysis

An intervention to increase physical activity in care home residents: results of a cluster-randomised, controlled feasibility trial (the REACH trial)

Cost‐effectiveness analysis of a multi‐dimensional intervention to reduce inappropriate antibiotic prescribing for children with upper respiratory tract infections in China

Risk-Adapted Therapy Directed According to Response (RADAR, UK-MRA Myeloma XV) - Comparing MRD-Guided Treatment Escalation and De-Escalation Strategies in Patients with Newly Diagnosed Myeloma Suitable for Stem Cell Transplantation

Fitness, a UK Myeloma Research Alliance (UK-MRA) Frailty-Adjusted Therapy Study, Supports the Feasibility of Recruiting Frail Newly Diagnosed Myeloma Patients to Large Clinical Trials

Cost-effectiveness of gasless laparoscopy as a means to increase provision of minimally invasive surgery for abdominal conditions in rural North-East India

F railty-adjusted therapy i n T ransplant N on- E ligible patient s with newly diagno s ed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial

Frailty-Adjusted Therapy in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (FiTNEss): A UK Myeloma Research Alliance Study, Myeloma XIV

Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa

Suchergebnisse filtern